Rachel Würstlein

945 total citations
58 papers, 465 citations indexed

About

Rachel Würstlein is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rachel Würstlein has authored 58 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 29 papers in Cancer Research and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rachel Würstlein's work include Breast Cancer Treatment Studies (28 papers), Advanced Breast Cancer Therapies (22 papers) and HER2/EGFR in Cancer Research (15 papers). Rachel Würstlein is often cited by papers focused on Breast Cancer Treatment Studies (28 papers), Advanced Breast Cancer Therapies (22 papers) and HER2/EGFR in Cancer Research (15 papers). Rachel Würstlein collaborates with scholars based in Germany, Switzerland and Italy. Rachel Würstlein's co-authors include Nadia Harbeck, Christoph Thomssen, Marija Balić, Michael Gnant, Christoph Kowalski, Nicole Ernstmann, Rainer Weber, Sarah Halbach, J. Hilfrich and Gϋnter von Minckwitz and has published in prestigious journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Rachel Würstlein

49 papers receiving 458 citations

Peers

Rachel Würstlein

ONCOL

PRM

GENET

PHEOH

Tallal Younis Canada

Emmanuelle Mouret‐Fourme France

Pedro Exman United States

Tjoung‐Won Park‐Simon Germany

Sumitra Ananda Australia

S. Jezdic Italy

Eva Blondeaux Italy

Luisa Bonilla Canada

Monica Zuradelli Italy

Mark A. Silberman United States

Tallal Younis Canada

Rachel Würstlein

331 ×1.3

ONCOL

118 ×0.7

PRM

165 ×1.2

80 ×1.0

GENET

80 ×1.2

PHEOH

Citations per year, relative to Rachel Würstlein Rachel Würstlein (= 1×) peers Tallal Younis

Countries citing papers authored by Rachel Würstlein

Since Specialization

Citations

This map shows the geographic impact of Rachel Würstlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Würstlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Würstlein more than expected).

Fields of papers citing papers by Rachel Würstlein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Würstlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Würstlein. The network helps show where Rachel Würstlein may publish in the future.

Co-authorship network of co-authors of Rachel Würstlein

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Würstlein. A scholar is included among the top collaborators of Rachel Würstlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Würstlein. Rachel Würstlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michaeli, Julia Caroline, Thomas Michaeli, Dario Trapani, et al.. (2024). Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price. Breast Cancer. 31(6). 1144–1155. 2 indexed citations

Corradini, Stefanie, Icro Meattini, Manfred Braun, et al.. (2024). Final Results from the SAVE-HEART Study - Surface-Based Deep Inspiration Breath-Hold Radiotherapy in Left-Sided Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). e304–e305.

Welslau, Manfred, et al.. (2024). 262TiP PROVIDENCE: A prospective, non-interventional study examining real-world clinical and patient-reported outcome (PRO) data in patients (pts) with HER2-positive or HER2-low unresectable or metastatic breast cancer (mBC) treated with trastuzumab deruxtecan. ESMO Open. 9. 103283–103283. 1 indexed citations

Ditsch, Nina, Michael Untch, Peter A. Fasching, et al.. (2024). ABC7 Consensus: Assessment by a German Group of Experts. Breast Care. 19(2). 116–128. 1 indexed citations

Schönecker, Stephan, Andrew R. Zinn, C. Heinz, et al.. (2024). Surface-based deep inspiration breath-hold radiotherapy in left-sided breast cancer: final results from the SAVE-HEART study. ESMO Open. 9(12). 103993–103993. 2 indexed citations

Hamann, Moritz, Oleg Gluz, Ulrike Nitz, et al.. (2024). 121P Endocrine response assessment in HR+ HER2- early breast cancer: Concordance of central versus local Ki67 measurements in the ADAPTcycle trial. ESMO Open. 9. 103109–103109. 1 indexed citations

Stefan, Alexandra, Alexander König, Nadia Harbeck, & Rachel Würstlein. (2023). Supportivtherapie bei Brustkrebs. Im Focus Onkologie. 26(2). 35–42.

Stefan, Alexandra, Alexander König, Nadia Harbeck, & Rachel Würstlein. (2023). Supportivtherapie bei Brustkrebs. PubMed Central. 28(3). 24–31.

Harbeck, Nadia, Ronald Kates, Timo Schinköthe, et al.. (2023). 195P Impact of an interactive eHealth system for patient reported outcomes on safety in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy. ESMO Open. 8(1). 101384–101384. 1 indexed citations

10.

Rogowski, Paul, Stephan Schönecker, Montserrat Pazos, et al.. (2023). Adjuvant Therapy for Elderly Breast Cancer Patients after Breast-Conserving Surgery: Outcomes in Real World Practice. Cancers. 15(8). 2334–2334. 1 indexed citations

11.

Untch, Michael, Peter A. Fasching, Renate Haidinger, et al.. (2022). Advanced Breast Cancer. Geburtshilfe und Frauenheilkunde. 82(10). 1044–1054. 4 indexed citations

12.

Lüftner, Diana, Peter A. Fasching, Renate Haidinger, et al.. (2022). ABC6 Consensus: Assessment by a Group of German Experts. Breast Care. 17(1). 90–100. 6 indexed citations

13.

Harbeck, Nadia, Oleg Gluz, Rachel Würstlein, et al.. (2021). The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials. The Breast. 59. 58–66. 6 indexed citations

14.

Schönecker, Stephan, Cristoforo Simonetto, Markus Eidemüller, et al.. (2020). Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks. Radiation Oncology. 15(1). 117–117. 28 indexed citations

15.

Halbach, Sarah, et al.. (2019). Male Breast Cancer Patients’ Perspectives on Their Health Care Situation: A Mixed-Methods Study. Breast Care. 15(1). 22–29. 20 indexed citations

16.

König, Alexander, et al.. (2019). EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients. Breast Care. 15(2). 171–177. 8 indexed citations

17.

Witzel, Isabell, Elena Laakmann, Rudolf Weide, et al.. (2018). Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry. European Journal of Cancer. 102. 1–9. 62 indexed citations

18.

Würstlein, Rachel, et al.. (2017). Tastbefund an der Brust: Auch bei Männern immer abklären!. MMW - Fortschritte der Medizin. 159(21-22). 67–72. 3 indexed citations

19.

Gluz, Oleg, Ulrike Nitz, Matthias Christgen, et al.. (2017). Prognostic impact of recurrence score (RS), grade/Ki67 central pathological review, and acycline (A)-free vs. A-containing chemotherapy (CT) on distant and locoregional disease-free survival (DDFS/LRFS) in high clinical risk HER2- early breast cancer (EBC): WSG PlanB trial results. Annals of Oncology. 28. v606–v606. 1 indexed citations

20.

Hermelink, Kerstin, et al.. (2014). Brief Distress Screening in Clinical Practice: Does it Help to Effectively Allocate Psycho-Oncological Support to Female Cancer Inpatients?. Breast Care. 9(2). 129–129. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact